ARTICLE | Company News
Texas Biotech deal
November 14, 1994 8:00 AM UTC
The Houston company's shareholders approved TXB's previously announced acquisition of ImmunoPharmaceutics, a San Diego developer of small molecule therapeutics. TXB paid ImmunoPharmaceutics 1.6 millio...